News Conference News AHA 2023 NOW PUBLISHED - AZALEA-TIMI 71: Bleeds Plunge With Abelacimab vs Rivaroxaban in AF, but Stroke Impact Unclear L.A. McKeown November 12, 2023
News Daily News ‘Overwhelming Reduction’ in Bleeding With Abelacimab vs Rivaroxaban in AF L.A. McKeown September 18, 2023
News Daily News Pre-TAVI PCI Linked to More Late Bleeding, With Implications for Survival L.A. McKeown September 14, 2023
News Features Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar L.A. McKeown May 12, 2023
News Daily News More AF Surveillance Needed in Chemotherapy Trials, Meta-analysis Hints L.A. McKeown April 06, 2023
News Conference News AHA 2022 Atrial Fibrosis Mediated by Gum Disease May Be Missing AF Link L.A. McKeown November 01, 2022
News Daily News VITAL Rhythm Data May Flip the Script on AF Screening in Women L.A. McKeown September 08, 2022
News Conference News ESC 2022 DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark L.A. McKeown August 30, 2022
News Daily News NCDR Analyses Offer Insights Into First-Generation Watchman Outcomes L.A. McKeown May 03, 2022
News Daily News Fewer Diabetic Complications Seen When NOACs Given for AF L.A. McKeown February 22, 2022
News Conference News AHA 2021 Small CRAVE Trial Reassures on Caffeine Safety in Rhythm Disorders L.A. McKeown November 14, 2021